Gene therapy: No improvement in outcomes with gene therapy for heart failure

@article{FernandezRuiz2016GeneTN,
  title={Gene therapy: No improvement in outcomes with gene therapy for heart failure},
  author={Irene Fernández-Ruíz},
  journal={Nature Reviews Cardiology},
  year={2016},
  volume={13},
  pages={122-123}
}
2 Citations

RNA Sequencing Reveals Novel Transcripts from Sympathetic Stellate Ganglia During Cardiac Sympathetic Hyperactivity

Key changes in the transcriptome in normotensive and spontaneously hypertensive rats are identified, suggesting that key genes coupled to neurotransmission are conserved and may provide novel targets for future interventions aimed at treating sympathetic hyperactivity associated with cardiovascular disease and other dysautonomias.

New insights into SERCA2a gene therapy in heart failure: pay attention to the negative effects of B-type natriuretic peptides

The current knowledge of SERCA2a gene therapy for heart failure is summarised, potential interaction between BNP levels and therapeutic effects ofSERCA 2a gene transfer is analysed and directions for future research to solve the identified problems are provided.